Bellevue Group’s Bicycle Therapeutics BCYC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-16,000
| Closed | -$324K | – | 166 |
|
|
2024
Q2 | $324K | Buy |
16,000
+3,500
| +28% | +$70.8K | 0.01% | 138 |
|
|
2024
Q1 | $311K | Sell |
12,500
-7,500
| -38% | -$187K | ﹤0.01% | 145 |
|
|
2023
Q4 | $362K | Sell |
20,000
-19,200
| -49% | -$347K | 0.01% | 142 |
|
|
2023
Q3 | $788K | Buy |
39,200
+14,200
| +57% | +$285K | 0.01% | 137 |
|
|
2023
Q2 | $638K | Sell |
25,000
-28,200
| -53% | -$720K | 0.01% | 139 |
|
|
2023
Q1 | $1.13M | Sell |
53,200
-17,000
| -24% | -$362K | 0.02% | 126 |
|
|
2022
Q4 | $2.08M | Sell |
70,200
-27,900
| -28% | -$826K | 0.03% | 124 |
|
|
2022
Q3 | $2.28M | Buy |
98,100
+13,700
| +16% | +$319K | 0.03% | 120 |
|
|
2022
Q2 | $1.42M | Buy |
84,400
+47,900
| +131% | +$804K | 0.02% | 134 |
|
|
2022
Q1 | $1.6M | Sell |
36,500
-17,200
| -32% | -$755K | 0.02% | 140 |
|
|
2021
Q4 | $3.27M | Sell |
53,700
-12,000
| -18% | -$731K | 0.03% | 135 |
|
|
2021
Q3 | $2.73M | Buy |
+65,700
| New | +$2.73M | 0.03% | 142 |
|